Project Details
Description
COG ACNS1021 - A Phase II Study of Sunitinib (NSC# 736511, IND# 74019) in Recurrent, Refractory or Progressive
| Status | Finished |
|---|---|
| Effective start/end date | 10/2/12 → 12/31/14 |
Funding
- THE CHILDREN'S HOSPITAL OF PHILADELPHIA
- PFIZER, INC.
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.